Maturitas
Volume 56, Issue 2 , Pages 161-172 , 20 February 2007

Menopause characteristics of women with physical disabilities from poliomyelitis

  • Claire Z. Kalpakjian

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Michigan Health System, 300 N. Ingalls, NI 2A09, Ann Arbor, MI 48109-0491, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 734 763 9374; fax: +1 734 936 5492.
    • ,
  • Elisabeth H. Quint

      Affiliations

    • Department of Obstetrics and Gynecology, University of Michigan Health System, Ann Arbor, MI, United States
    • ,
  • Denise G. Tate

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Michigan Health System, 300 N. Ingalls, NI 2A09, Ann Arbor, MI 48109-0491, United States
    • ,
  • Sunny Roller

      Affiliations

    • National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitation, U.S. Department of Education, Washington, DC, United States
    • ,
  • Loren L. Toussaint

      Affiliations

    • Department of Psychology, Luther College, Decorah, IA, United States

Received 10 October 2005 ,Revised 11 July 2006 ,Accepted 21 July 2006.

References 

  1. Welner SL. Introduction to the special issue. Sexuality Disabil. 1999;17(3):183–186
  2. Welner SL, Simon JA, Welner B. Maximizing health in menopausal women with disabilities. Menopause. 2002;9(3):208–219
  3. Vandenakker CB, Glass DD. Menopause and aging with disability. Phys Med Rehabil Clin N Am. 2001;12(1):133–151
  4. Sowers M, Pope S, Welch G, Sternfeld B, Albrecht G. The association of menopause and physical functioning in women at midlife. J Am Geriatr Soc. 2001;49(11):1485–1492
  5. Jacobsen D, Gange S, Rose N, Graham N. Epidemiology and estimated population burden of selected autoimmune disorders in the United States. Clin Immunol Immunopathol. 1997;84(3):223–243
  6. Smith R, Studd J. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med. 1992;85:612–613
  7. Wluka A, Cicuttini F, Spector T. Menopause, oestrogens and arthritis. Maturatis. 2000;35:183–199
  8. Harden CL, Koppel BS, Herzog AG, Nikolov BG, Hauser WA. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology. 2003;61(4):451–455
  9. Liporace J, D’Abreu A. Epilepsy and women's health: Family planning, bone health, menopause, and menstrual-related seizures. Mayo Clin Proc. 2003;78(4):497–506
  10. Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with MS. Neurology. 1998;51:1161–1165
  11. Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 1993;36(11):1510–1516
  12. Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology. 2000;54(12):2292–2298
  13. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol. 1998;51(12):1271–1276
  14. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18(1):199–206
  15. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis. 1987;40(11):995–1002
  16. Hardy R, Kuh D. Social and environmental conditions across the life course and age at menopause in a British birth cohort study. BJOG. 2005;112(3):346–354
  17. Schupf N, Zigman W, Kapell D, Lee JH, Kline J, Levin B. Early menopause in women with Down's syndrome. J Intellect Disabil Res. 1997;41(Pt 3):264–267
  18. Becker H, Stuifbergen A, Gordon D. Menopausal experiences and hormone replacement therapy use among women with physical impairments. Womens Health Issues. 2002;12(4):212–219
  19. Becker H, Stuifbergen AK, Gordon D. The decision to take hormone replacement therapy among women with disabilities. West J Nurs Res. 2002;24(3):264–281
  20. Kalpakjian CZ, Riley BB, Quint EH, Tate DG. Hormone replacement therapy and health behavior in postmenopausal polio survivors. Maturitas. 2004;48(4):398–410
  21. Jubelt B, Agre JC. Characteristics and management of postpolio syndrome. JAMA. 2000;284(4):412–414
  22. In:  Halstead L,  Naierman N editor. Managing post-polio: A guide to living well with post polio syndrome. Washington, DC: NRH Press; 1998;
  23. Taylor SM, Kinney AM, Kline JK. Menopausal transition: predicting time to menopause for women 44 years or older from simple questions on menstrual variability. Menopause. 2004;11(1):40–48
  24. Burger HG, Robertson DM, Baksheev L, Collins A, Csemiczky G, Landgren BM. The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause. Menopause. 2005;12(3):267–274
  25. Soules M. Executive summary: stages of reproductive aging workshop (STRAW) Park City, Utah, July 2001. Menopause. 2001;8(6):402–407
  26. Perz J. Development of the menopause symptom list: a factor analytic study of menopause associated symptoms. Women Health. 1997;25(1):53–69
  27. Kalpakjian C, Toussaint L, Quint E, Reame N. Use of a standardized menopause symptom rating scale in a sample of women with physical disabilities. Menopause. 2005;12(1):78–87
  28. Jette A, Davies A. The functional status questionnaire: reliability and validity when used in primary care. J Gen Intern Med. 1986;1:143–149
  29. Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2002.
  30. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in health postmenopausal women. JAMA 2002;288(3):321–33.
  31. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1):47–53
  32. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the women's health initiative. JAMA. 2004;292(16):1983–1988
  33. Buist DSM, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004;104(5):1042–1050
  34. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, JN: Erlbaum; 1988;
  35. Kalpakjian C, Toussaint L, Quint E, Reame N. The use of a standardized menopause symptom rating scale in a sample of women with physical disabilities. Menopause. 2004;12(1):78–87
  36. Holte A, Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturatis. 1991;13:205–215
  37. Holte A. Menopause, mood and hormone replacement therapy: methodological issues. Maturatis. 1998;29:5–18
  38. Holte A, Mikkelsen A. The menopausal syndrome: a factor analytic replication. Maturatis. 1991;13:193–203
  39. Bastian LA, Smith CM, Nanda K. Is this woman perimenopausal?. JAMA. 2003;289(7):895–902
  40. Freedman R. Physiology of hot flashes. Am J Hum Biol. 2001;13:453–464
  41. Wysowski DK, Governale LA. Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiol Drug Saf. 2005;14(3):171–176
  42. Welner SL. Menopausal issues. Sexuality Disabil. 1999;17(3):259–267
  43. Grady D. Postmenopausal hormones—therapy for symptoms only. N Engl J Med. 2003;348(19):
  44. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13):1573–1580
  45. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 2004;291(14):1701–12.
  46. Jackson AB, Wadley V. A multicenter study of women's self-reported reproductive health after spinal cord injury. Arch Phys Med Rehabil. 1999;80(11):1420–1428
  47. Nosek M, Rintala D, Young M, et al. Sexual functioning among women with physical disabilities. Arch Phys Med Rehabil. 1996;77(2):107–115
  48. Calvaresi E, Bryan J. Symptom experience in Australian men and women in midlife. Maturatis. 2003;44:225–236
  49. Van Hall E, Verdel M, Van der Velden J. “Perimenopausal” complaints in women and men: A comparative study. J Womens Health. 1994;3(1):45–49
  50. Sherman S, Goldstein R, Crawford S, Ory M, Guralnik J. Menopause and six chronic conditions of aging: the study of women's health across the nation (SWAN). In:  Aso T,  Yanaihara T,  Fujimoto S editor. The menopause at the millenium: the 9th international menopause society world congress on the menopause. New York, NY: Parthenon Publishing Group; 1999;p. 221–228
  51. Kalpakjian CZ, Toussaint LL, Quint EH, Reame NK. Use of a standardized menopause symptom rating scale in a sample of women with physical disabilities. Menopause. 2005;12(1):78–87

PII: S0378-5122(06)00279-9

doi: 10.1016/j.maturitas.2006.07.006

Maturitas
Volume 56, Issue 2 , Pages 161-172 , 20 February 2007

Article Tools